YU14284A - Process for making 3-amino substituted derivatives of pyridazine - Google Patents

Process for making 3-amino substituted derivatives of pyridazine

Info

Publication number
YU14284A
YU14284A YU00142/84A YU14284A YU14284A YU 14284 A YU14284 A YU 14284A YU 00142/84 A YU00142/84 A YU 00142/84A YU 14284 A YU14284 A YU 14284A YU 14284 A YU14284 A YU 14284A
Authority
YU
Yugoslavia
Prior art keywords
pyridazine
making
substituted derivatives
amino substituted
amino
Prior art date
Application number
YU00142/84A
Other languages
English (en)
Inventor
J P Chambon
K Biziere
C G Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of YU14284A publication Critical patent/YU14284A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
YU00142/84A 1983-01-27 1984-01-27 Process for making 3-amino substituted derivatives of pyridazine YU14284A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
YU14284A true YU14284A (en) 1986-12-31

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00142/84A YU14284A (en) 1983-01-27 1984-01-27 Process for making 3-amino substituted derivatives of pyridazine

Country Status (27)

Country Link
US (1) US4721711A (is)
EP (1) EP0117779B1 (is)
JP (1) JPS59141564A (is)
KR (1) KR910000638B1 (is)
AR (1) AR240045A1 (is)
AT (1) ATE48417T1 (is)
AU (2) AU2372984A (is)
CA (1) CA1238637A (is)
DD (1) DD220026A5 (is)
DE (1) DE3480653D1 (is)
DK (1) DK162985C (is)
ES (1) ES529081A0 (is)
FI (1) FI78691C (is)
FR (1) FR2540113A1 (is)
HU (1) HU193890B (is)
IE (1) IE57054B1 (is)
IL (1) IL70756A (is)
MA (1) MA20018A1 (is)
NO (1) NO840313L (is)
NZ (1) NZ206945A (is)
OA (1) OA07644A (is)
PH (1) PH21162A (is)
PL (1) PL142340B1 (is)
PT (1) PT77993B (is)
SG (1) SG93690G (is)
YU (1) YU14284A (is)
ZA (1) ZA84502B (is)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
ES2543813T3 (es) 2004-11-02 2015-08-24 Northwestern University Compuestos de piridazina para el tratamiento de enfermedades inflamatorias
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
WO2007127474A2 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
WO2007127375A2 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
US20100168120A1 (en) * 2006-04-28 2010-07-01 Neuromedix Inc. Salts of pyridazine compounds
JP2010523579A (ja) * 2007-04-02 2010-07-15 インスティテュート フォア ワンワールド ヘルス Ｃｆｔｒ阻害剤化合物およびそれらの使用
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
WO2009131957A2 (en) 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
EP2341776A4 (en) * 2008-09-19 2012-05-30 Inst Oneworld Health COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING IMIDAZOL AND TRIAZOL DERIVATIVES
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
CA1218655A (en) * 1983-01-28 1987-03-03 Kathleen Biziere Process for the preparation of pyridazine derivatives having a psychotropic action

Also Published As

Publication number Publication date
AU2372984A (en) 1984-08-02
DD220026A5 (de) 1985-03-20
DK162985B (da) 1992-01-06
IL70756A0 (en) 1984-04-30
PT77993A (fr) 1984-02-01
DK38984A (da) 1984-07-28
NZ206945A (en) 1987-07-31
AU652118B2 (en) 1994-08-18
MA20018A1 (fr) 1984-10-01
SG93690G (en) 1991-01-18
OA07644A (fr) 1985-05-23
ATE48417T1 (de) 1989-12-15
US4721711A (en) 1988-01-26
ES8500243A1 (es) 1984-10-01
EP0117779A1 (fr) 1984-09-05
FI78691C (fi) 1989-09-11
ES529081A0 (es) 1984-10-01
CA1238637A (en) 1988-06-28
FI78691B (fi) 1989-05-31
KR840007586A (ko) 1984-12-08
DK162985C (da) 1992-06-01
PL245931A1 (en) 1985-07-16
NO840313L (no) 1984-07-30
FI840323A (fi) 1984-07-28
JPS59141564A (ja) 1984-08-14
PH21162A (en) 1987-08-05
ZA84502B (en) 1984-09-26
PT77993B (fr) 1986-04-10
EP0117779B1 (fr) 1989-12-06
IL70756A (en) 1987-03-31
FR2540113B1 (is) 1985-05-17
IE57054B1 (en) 1992-04-08
DK38984D0 (da) 1984-01-27
PL142340B1 (en) 1987-10-31
FI840323A0 (fi) 1984-01-26
AU2142188A (en) 1989-03-16
DE3480653D1 (de) 1990-01-11
FR2540113A1 (fr) 1984-08-03
KR910000638B1 (ko) 1991-01-31
AR240045A1 (es) 1990-01-31
IE840149L (en) 1984-07-27
HU193890B (en) 1987-12-28

Similar Documents

Publication Publication Date Title
YU14284A (en) Process for making 3-amino substituted derivatives of pyridazine
YU108384A (en) Process for making derivatives of 3(2h)-pyridazinone
HUT37619A (en) Process for production of new ganine derivatives
YU169684A (en) Process for preparation of 1-benzyl-aminomethyl-pyrolidinones
EG15747A (en) Process for preparing derivatives of pyridazine process for preparing substituted derivatives of pyridazine
YU144784A (en) Process for preparation of benzocycloalkane derivatives
YU14184A (en) Process for making new derivatives of cyano-4-pyridiazine
YU43390B (en) Process for preparation of new phenolsulphonphtaleinyle-beta-d-galactosides
EG15749A (en) Process for preparing derivatives of pyridazine
HUT36089A (en) Process for production of new aminoguanidin derivatives
YU135884A (en) Process for making derivatives of piperidino-hynazoline
YU42634B (en) Process for obtaining fluoro-substituted derivatives of bis-triazole
PL246664A1 (en) Process for preparing novel derivatives of bis-triazole
HUT35685A (en) Process for producing cristalline modifications of cepheme-carboxylic acid derivatives
HUT35263A (en) Process for production of 2-mercapto-piramido-hexahydrokinolin derivatives
YU168284A (en) Process for making new derivatives of hinazoline
YU44241B (en) Process for making derivatives of 2-azacyclothiopenem
HUT36136A (en) Process for production of 6-dezoxi-antraciklin derivatives
HUT36477A (en) Process for producing substituted spiro-derivatives of pyridine
YU76584A (en) Process for making pharmaceutically active derivatives of pyridazine
YU182185A (en) Process for producing derivatives of bromdichlorimidazole
YU123084A (en) Process for making derivatives of propan-2-ole
YU136884A (en) Process for making derivatives of methionine-hydroxy analogs
PL247174A1 (en) Process for preparing derivatives of pyrimidinotrione
GB2165836B (en) Process of producing guanidinothiazole derivatives